GlassScriptPhysician profile
Pooja Puri
NPI 1508097387
$1,720.62
in general payments reported to CMS, 2019-2025
17 companies · $20.75 in 2025
The $20.75 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,303 · 2020: $269 · 2021: $63.49 · 2022: $48.56 · 2024: $15.94 · 2025: $20.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $36.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $36.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $255.47 | 2019-2020 | |
| Advanced Respiratory, INC | $249.73 | 2019-2021 | |
| Glaxosmithkline, LLC. | $211.73 | 2019-2020 | |
| Gilead Sciences, INC. | $161.47 | 2019 | |
| Abbvie INC. | $157.92 | 2019-2025 | |
| Philips North America LLC | $144.82 | 2019-2020 | |
| Genentech USA, INC. | $144.54 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $85.69 | 2019-2022 | |
| Allergan, INC. | $77.27 | 2019 | |
| Sobi, INC | $55.92 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $45.54 | 2019-2020 | |
| Genzyme Corporation | $36.60 | 2019 | |
| Alcresta Therapeutics, INC. | $19.84 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.52 | 2019 | |
| Chiesi USA, INC. | $18.72 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pari Respiratory Equipment, INC. | $18.63 | 2019 | |
| Fisher & Paykel Healthcare INC | $17.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Puri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.